시장보고서
상품코드
2036055

풀형 CRISPR 스크리닝 시장 보고서(2026년)

Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,904,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,979,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 13,055,000
※ 부가세 별도
한글목차
영문목차

풀형 CRISPR 스크리닝 시장 규모는 최근 급성장하고 있습니다. 이 시장은 2025년 13억 달러에서 2026년에는 15억 1,000만 달러로, CAGR 15.9%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 기능 유전체학에 대한 수요 증가, CRISPR-Cas9 기술의 보급 확대, 제약 분야 연구개발(R&D)의 확대, 유전자 편집 도구의 발전, 학술 연구 프로그램의 확대 등을 꼽을 수 있습니다.

풀형 CRISPR 스크리닝 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년에는 27억 4,000만 달러에 이르고, CAGR은 16.1%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 AI를 활용한 유전자 스크리닝, 클라우드 기반 유전체학 플랫폼과의 통합, 맞춤형 의료 용도에 대한 수요, 생명공학 인프라 확대, 하이스루풋 스크리닝 자동화 등을 꼽을 수 있습니다. 예측 기간의 주요 트렌드에는 하이스루풋 스크리닝 기술, 멀티오믹스 데이터와의 통합, 자동화된 CRISPR 워크플로우, AI 기반 유전자 표적 식별, 실시간 기능유전체학 분석 등이 포함될 것으로 보입니다.

유전성 질환의 유병률 증가가 풀형 CRISPR 스크리닝 시장 확대를 견인할 것으로 예측됩니다. 유전성 질환은 개인의 DNA의 유전적 또는 후천적 이상에 의해 발생하는 질환으로 정상적인 발달, 대사 또는 생리적 기능에 영향을 미치는 질환을 말합니다. 이러한 질병의 유병률 증가는 부모의 고령화, 진단 능력의 향상, 유전자 검사 보급 등의 요인에 기인하며, 이러한 요인들은 모두 검출률과 보고율의 향상에 기여하고 있습니다. 풀형 CRISPR 스크리닝은 질병 관련 유전자 및 조절 경로를 유전체 전체에서 높은 처리량으로 확인할 수 있기 때문에 유전성 질환 연구에 필수적입니다. 예를 들어, 2024년 10월 낭포성 섬유증 환자를 지원하는 영국의 자선단체 '낭포성 섬유증 트러스트(Cystic Fibrosis Trust)는 2022년 약 1만 1,148명의 낭포성 섬유증 환자가 등록되었고, 2023년에는 1만 1,318명으로 증가하여 전년 대비 약 1.5%의 성장률을 보였다고 보고했습니다. 그 결과, 유전성 질환의 유병률 증가가 풀형 CRISPR 스크리닝 시장의 성장을 견인하고 있습니다.

풀 기반 CRISPR 스크리닝 시장에서 활동하는 주요 기업들은 치료 및 연구용 고처리량 기능 유전체학 및 유전자 표적의 정확한 식별을 위해 트랜스크립톰 와이드 프로파일링과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 하고 있습니다. 트랜스크립톰-와이드 프로파일링은 특정 시점에 세포나 조직에서 발현되는 모든 RNA 전사체를 종합적으로 분석하여 유전자 활성, 조절 및 세포 기능에 대한 지식을 제공합니다. 예를 들어, 2023년 6월, 미국에 본사를 둔 생명공학 기업 파스 바이오사이언스(Parse Biosciences Inc.)는 대규모 단일 세포 풀형 CRISPR 스크리닝을 가능하게 하는 기술인 'CRISPR Detect'를 발표하였습니다. 이 혁신적 기술은 에버코드 전사체(Evercode Whole Transcriptome) 플랫폼과 통합되어 Cas12 기반 단일가이드 RNA(sgRNA)를 이용한 개별 유전자 교란과 실험당 최대 100만 개의 세포에 걸친 전체 전사체 발현 프로파일을 결합하여 기존 액적 기반 단일 세포 RNA-seq의 처리 능력과 비용의 장벽을 극복하고 있습니다. 이를 통해 유전체 규모의 유전자 기능 분석, 조절 네트워크, 신호전달 경로 및 신약개발의 적용 범위가 표적 검증을 넘어 확장됩니다.

자주 묻는 질문

  • 풀형 CRISPR 스크리닝 시장 규모는 어떻게 변화하고 있나요?
  • 풀형 CRISPR 스크리닝 시장의 성장 요인은 무엇인가요?
  • 유전성 질환의 유병률 증가가 풀형 CRISPR 스크리닝 시장에 미치는 영향은 무엇인가요?
  • 풀형 CRISPR 스크리닝 시장에서 활동하는 주요 기업은 어디인가요?
  • 풀형 CRISPR 스크리닝의 주요 기술 트렌드는 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남아메리카 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 시장에 등장 예정 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

JHS 26.05.29

Pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening is a high-throughput genetic method that applies CRISPR-Cas systems to simultaneously modify or knock out multiple genes in a cell population. It allows researchers to pinpoint genes involved in specific cellular functions, disease mechanisms, or drug responses by observing the effects of these targeted changes across the pooled cells.

The primary screening types of pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening include genome-wide screening and targeted screening. Genome-wide screening analyzes the entire genome to identify genes, variants, or mutations associated with specific traits, diseases, or biological functions. Product types include libraries, reagents and kits, instruments, software, and services, using technologies such as CRISPR-Cas9 screening, CRISPR interference screening, and CRISPR activation screening. Applications cover functional genomics, drug discovery, cancer research, gene regulation, and other fields, serving pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end users.

Tariffs have influenced the pooled CRISPR screening market by increasing import costs for specialized instruments, reagents, and libraries. This impact is most significant for segments like instruments and reagents in regions such as North America and Europe that rely heavily on imports. While tariffs have temporarily slowed adoption, they are encouraging local manufacturing, investment in domestic production capabilities, and innovation in cost-effective solutions, ultimately supporting market resilience and diversification.

The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market research report is one of a series of new reports from The Business Research Company that provides pooled clustered regularly interspaced short palindromic repeats (crispr) screening market statistics, including pooled clustered regularly interspaced short palindromic repeats (crispr) screening industry global market size, regional shares, competitors with a pooled clustered regularly interspaced short palindromic repeats (crispr) screening market share, detailed pooled clustered regularly interspaced short palindromic repeats (crispr) screening market segments, market trends and opportunities, and any further data you may need to thrive in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening industry. This pooled clustered regularly interspaced short palindromic repeats (crispr) screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market size has grown rapidly in recent years. It will grow from $1.3 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to rising demand for functional genomics, increasing adoption of crispr-cas9 technology, growth of pharmaceutical r&d, advancements in gene editing tools, expansion of academic research programs.

The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market size is expected to see rapid growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to ai-enabled gene screening, integration with cloud-based genomics platforms, demand for personalized medicine applications, expansion of biotech infrastructure, automation in high-throughput screening. Major trends in the forecast period include high-throughput screening techniques, integration with multi-omics data, automated crispr workflows, ai-driven gene target identification, real-time functional genomics analysis.

The rising prevalence of genetic disorders is anticipated to drive the expansion of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market. Genetic disorders are conditions arising from inherited or acquired anomalies in an individual's DNA that impact normal development, metabolism, or physiological function. The growing prevalence of these disorders is partly due to factors such as advanced parental age, enhanced diagnostic capabilities, and broader genetic screening, all contributing to increased detection and reporting rates. Pooled CRISPR screening is essential in genetic disorder research, as it enables high-throughput, genome-wide identification of disease-associated genes and regulatory pathways. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity supporting individuals with cystic fibrosis, reported that approximately 11,148 cystic fibrosis patients were registered in 2022, rising to 11,318 in 2023, representing a year-over-year growth of around 1.5%. Consequently, the increasing prevalence of genetic disorders is fueling the growth of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market.

Key companies operating in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market are focusing on developing innovative solutions such as transcriptome-wide profiling to enable high-throughput functional genomics and precise identification of gene targets for therapeutic and research applications. Transcriptome-wide profiling refers to the comprehensive analysis of all RNA transcripts expressed in a cell or tissue at a given time, providing insights into gene activity, regulation, and cellular functions. For example, in June 2023, Parse Biosciences Inc., a US-based biotechnology company, launched CRISPR Detect, a technology enabling high-scale single-cell pooled CRISPR screens. This innovation integrates with the company's Evercode Whole Transcriptome platform to pair individual gene perturbations, via Cas12-based single guide ribonucleic acid (RNA) (sgRNAs), with whole-transcriptome expression profiles across up to one million cells per experiment, overcoming prior throughput and cost barriers in droplet-based single-cell RNA-seq. It expands applications in genome-scale gene function analysis, regulatory networks, signaling pathways, and drug discovery beyond targeted validation.

The rising research and development investments are expected to further propel the growth of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market. Research and development (R&D) investments involve allocating resources to create new products, enhance existing offerings, and advance technologies to foster innovation and long-term business growth. Technological advancements are encouraging higher research and development investments, as companies continuously innovate and refine products and processes to keep pace with rapid digital transformation and evolving industry standards. R&D investments support CRISPR screening by enabling the creation of advanced gene-editing tools, optimizing protocols, and improving accuracy and efficiency for faster gene function discovery. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net spending on research and development (R&D) rose to £17.4 billion ($22.1 billion) in 2023, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% increase. Therefore, the rising research and development investments are driving the growth of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market.

Major companies operating in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Applied Biological Materials Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., QIAGEN N.V., GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Element Biosciences Inc., Synthego Corporation, Bit.bio Limited, Bioneer Corporation, VectorBuilder Inc., Admera Health LLC, Addgene Inc., Creative Biogene Inc., Cellecta Inc., Vivlion Inc., GeneCopoeia Inc.

North America was the largest region in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market consists of revenues earned by entities by providing services such as CRISPR screening services, custom library design, assay development services, data analysis services, bioinformatics solutions, cell line engineering services, and validation studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market also includes sales of CO2 incubators, refrigerators and freezers, and automated liquid handling robots. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream research organizations, biotechnology firms, pharmaceutical companies, and academic institutions) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pooled clustered regularly interspaced short palindromic repeats (crispr) screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pooled clustered regularly interspaced short palindromic repeats (crispr) screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Screening Type: Genome Wide Screening; Targeted Screening
  • 2) By Product Type: Libraries; Reagents And Kits; Instruments; Software; Services
  • 3) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Screening; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Interference Screening; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Activation Screening
  • 4) By Application: Functional Genomics; Drug Discovery; Cancer Research; Gene Regulation; Other Applications
  • 5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End-Users
  • Subsegments:
  • 1) By Genome Wide Screening: Knockout Screening; Activation Screening; Interference Screening
  • 2) By Targeted Screening: Gene Specific Knockout; Gene Specific Activation; Gene Specific Interference
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Applied Biological Materials Inc.; Agilent Technologies Inc.; Charles River Laboratories International Inc.; QIAGEN N.V.; GenScript Biotech Corporation; Twist Bioscience Corporation; Ginkgo Bioworks Inc.; Element Biosciences Inc.; Synthego Corporation; Bit.bio Limited; Bioneer Corporation; VectorBuilder Inc.; Admera Health LLC; Addgene Inc.; Creative Biogene Inc.; Cellecta Inc.; Vivlion Inc.; GeneCopoeia Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 High-Throughput Screening Techniques
    • 4.2.2 Integration With Multi-Omics Data
    • 4.2.3 Automated Crispr Workflows
    • 4.2.4 Ai-Driven Gene Target Identification
    • 4.2.5 Real-Time Functional Genomics Analysis

5. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Companies
  • 5.2 Academic And Research Institutes
  • 5.3 Contract Research Organizations
  • 5.4 Hospitals And Clinical Research Centers
  • 5.5 Other End-Users

6. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Segmentation

  • 9.1. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genome Wide Screening, Targeted Screening
  • 9.2. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Libraries, Reagents And Kits, Instruments, Software, Services
  • 9.3. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Interference Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Activation Screening
  • 9.4. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Functional Genomics, Drug Discovery, Cancer Research, Gene Regulation, Other Applications
  • 9.5. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users
  • 9.6. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Sub-Segmentation Of Genome Wide Screening, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Knockout Screening, Activation Screening, Interference Screening
  • 9.7. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Sub-Segmentation Of Targeted Screening, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gene Specific Knockout, Gene Specific Activation, Gene Specific Interference

10. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Regional And Country Analysis

  • 10.1. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 11.1. Asia-Pacific Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 12.1. China Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 13.1. India Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 14.1. Japan Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 15.1. Australia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 16.1. Indonesia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 17.1. South Korea Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 18.1. Taiwan Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 19.1. South East Asia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 20.1. Western Europe Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 21.1. UK Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 22.1. Germany Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 23.1. France Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 24.1. Italy Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 25.1. Spain Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 26.1. Eastern Europe Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 27.1. Russia Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 28.1. North America Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 29.1. USA Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 30.1. Canada Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 31.1. South America Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 32.1. Brazil Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 33.1. Middle East Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

  • 34.1. Africa Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market, Segmentation By Screening Type, Segmentation By Product Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Regulatory and Investment Landscape

36. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Competitive Landscape And Company Profiles

  • 36.1. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Applied Biological Materials Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Other Major And Innovative Companies

  • Charles River Laboratories International Inc., QIAGEN N.V., GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Element Biosciences Inc., Synthego Corporation, Bit.bio Limited, Bioneer Corporation, VectorBuilder Inc., Admera Health LLC, Addgene Inc., Creative Biogene Inc., Cellecta Inc., Vivlion Inc.

38. Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market

41. Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market High Potential Countries, Segments and Strategies

  • 41.1 Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기